Description

Gen1E Lifesciences is a clinical-stage biopharmaceutical company currently in Phase 2 of clinical development. The company is focused on discovering and developing small molecule therapeutics that target the root causes of severe inflammatory and age-related diseases. Gen1E’s mission is to transform the treatment landscape for conditions with significant unmet medical needs by addressing the underlying molecular drivers of disease.